Inflammation and Immunity in Depression

Inflammation and Immunity in Depression

Basic Science and Clinical Applications
2018, Pages 85-102
Inflammation and Immunity in Depression

Chapter 5 - The Impact of Inflammation on Brain Function and Behavior in Rodent Models of Affective Disorders

https://doi.org/10.1016/B978-0-12-811073-7.00005-2Get rights and content

Abstract

Major depressive disorder (MDD) is a common psychiatric illness and has been identified as the leading cause of disability worldwide, by the World Health Organization. Anxiety disorders are also extremely common and often poorly treated. This makes it imperative to gain better insights into biological mechanisms mediating the pathogenesis of MDD and anxiety disorders. Recent years have witnessed increasing evidence supporting the involvement of inflammatory mechanisms in the pathophysiology of such affective disorders, thus paving the way for the field of psychoneuroimmunology. In this review, we highlight the effect of stress-induced cytokines on affective behavioral abnormalities, targeting some of the mechanisms involved in mood regulation, such as altered serotonin signaling; activation of the kynurenine pathway leading to serotonin clearance and accumulation of kynurenine metabolites; altered hippocampal neurogenesis, with a special focus on the role played by gut microbiome; and sex differences in mediating the inflammatory phenotype associated with behavioral alterations in rodent models.

References (0)

Cited by (3)

  • Komagataella pastoris KM71H modulates neuroimmune and oxidative stress parameters in animal models of depression: A proposal for a new probiotic with antidepressant-like effect

    2021, Pharmacological Research
    Citation Excerpt :

    Furthermore, quinurenine, the breakdown product of tryptophan, can cross the BBB where it is later metabolized to generate neuroactive glutamatergic compounds, such as quinoline acid [69]. Quinoline acid, in turn, exerts a neurotoxic effect acting as agonist of the N-methyl-d-aspartate receptor [69]. Evidence shows that high glutamate receptor activity and induced excitotoxicity cause significant neuronal damage in rodents [69,70].

View full text